Search Results - "Rostami, Am"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis by Das Sarma, Jayasri, Ciric, Bogoljub, Marek, Ryan, Sadhukhan, Sanjoy, Caruso, Michael L, Shafagh, Jasmine, Fitzgerald, Denise C, Shindler, Kenneth S, Rostami, Am

    Published in Journal of neuroinflammation (28-04-2009)
    “…Interleukin-17A (IL-17A) is the founding member of a novel family of inflammatory cytokines that plays a critical role in the pathogenesis of many autoimmune…”
    Get full text
    Journal Article
  2. 2

    Pathogenesis of immune-mediated neuropathies by Rostami, A M

    Published in Pediatric research (01-01-1993)
    “…A variety of peripheral neuropathies are believed to be immune-mediated. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome (GBS) is…”
    Get full text
    Journal Article
  3. 3

    Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis by Zhang, G X, Baker, C M, Kolson, D L, Rostami, A M

    Published in Multiple sclerosis (01-02-2000)
    “…In recent years we have seen growing evidence for the role of chemokines in the pathogenesis of several infectious and non-infectious inflammatory CNS disease…”
    Get full text
    Journal Article
  4. 4

    Treatment of Guillain-Barré syndrome with intravenous immunoglobulin by Sater, R A, Rostami, A

    Published in Neurology (01-12-1998)
    “…Guillain-Barré syndrome (GBS) is an acute polyneuropathy that typically presents as a progressive flaccid paralysis. The pathology is believed to be caused by…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis by Rostami, A.M., Sater, R.A., Bird, S.J., Galetta, S., Farber, R.E., Kamoun, M., Silberberg, D.H., Grossman, R.I., Pfohl, D.

    Published in Multiple sclerosis (01-03-1999)
    “…Extracorporeal photopheresis is a safe therapy for cutaneous T-cell lymphoma and may have efficacy in certain autoimmune disorders. We performed a randomized,…”
    Get full text
    Journal Article
  7. 7

    IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE) by Constantinescu, Cris S, Hilliard, Brendan, Wysocka, Maria, Ventura, Elvira S, Bhopale, Mahendra K, Trinchieri, Giorgio, Rostami, A.M

    Published in Journal of the neurological sciences (01-12-1999)
    “…Blockade of the CD40 ligand (CD40L)–CD40 interaction suppresses experimental autoimmune encephalomyelitis (EAE). Since this interaction induces IL-12, an…”
    Get full text
    Journal Article
  8. 8

    Chemokines and peripheral nerve demyelination by Fujioka, T, Kolson, D L, Rostami, A M

    Published in Journal of neurovirology (01-02-1999)
    “…It has been speculated that beta-chemokines play a pivotal role in the development of peripheral nervous system (PNS) disorders characterized by mononuclear…”
    Get more information
    Journal Article
  9. 9

    Pathogenesis of neuroimmunologic diseases. Experimental models by Constantinescu, C S, Hilliard, B, Fujioka, T, Bhopale, M K, Calida, D, Rostami, A M

    Published in Immunologic research (1998)
    “…Animal models of autoimmune diseases have greatly improved our current understanding of the pathogenesis of human autoimmunity and have provided the potential…”
    Get full text
    Journal Article
  10. 10

    Magnetic resonance imaging of the cauda equina in Guillain-Barré syndrome by CRINO, P. B, ZIMMERMAN, R, LASKOWITZ, D, RAPS, E. C, ROSTAMI, A. M

    Published in Neurology (01-07-1994)
    “…We report three patients (two children and one adult) with Guillain-Barré syndrome and magnetic resonance imaging evidence of gadolinium enhancement of the…”
    Get full text
    Journal Article
  11. 11

    Anti-interleukin-12 antibody: potential role in preventing relapses of multiple sclerosis by Fox, R J, Rostami, A M

    “…Multiple sclerosis is an inflammatory demyelinating disorder of the central nervous system. Immunological evidence from patients with multiple sclerosis and…”
    Get full text
    Journal Article
  12. 12

    Guillain-Barré syndrome: clinical and immunological aspects by Rostami, A M

    Published in Springer seminars in immunopathology (01-07-1995)
    “…Immune-mediated PNS disorders comprise a significant segment of diseases of the nervous system. Studies on GBS as a prototype of these disorders and its…”
    Get more information
    Journal Article
  13. 13

    A new two-stage dynamic holdoff time scheme for enhancement of signaling messages in IEEE 802.16 mesh networks by Rostami, A., Rostami, A., Zokaei, S., Zakeri, Y.

    “…The IEEE 802.16(d) standard generally defines two operational modes: the Point-to-Multi-Point mode and the mesh mode. Because of mesh mode advantages over…”
    Get full text
    Conference Proceeding
  14. 14

    Free light chains in multiple sclerosis urine by Mehta, P D, Cook, S D, Coyle, P K, Troiano, R A, Constantinescu, C S, Rostami, A M

    Published in Multiple sclerosis (01-06-1998)
    “…We measured free kappa (kappa) and lambda (lambda) light chains in urine from patients with definite multiple sclerosis (MS), other neurologic diseases (OND),…”
    Get more information
    Journal Article
  15. 15

    Serial evoked potential studies and MRI imaging in chronic progressive multiple sclerosis by Sater, Richard A, Rostami, A.M, Galetta, Steven, Farber, Roger E, Bird, Shawn J

    Published in Journal of the neurological sciences (15-12-1999)
    “…Measurements of serial evoked potential latencies and plaque burden on MRI scans are often obtained during clinical studies of multiple sclerosis patients to…”
    Get full text
    Journal Article
  16. 16

    Urinary free kappa light chain levels in chronic progressive multiple sclerosis by Constantinescu, C S, Mehta, P D, Rostami, A M

    Published in Pathobiology (Basel) (1994)
    “…Previous studies have shown elevated levels of free kappa light chains (FKLC) in the urine of patients with relapsing-remitting multiple sclerosis (MS). The…”
    Get more information
    Journal Article
  17. 17

    Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders by Rostami, A M, Burns, J B, Eccleston, P A, Manning, M C, Lisak, R P, Silberberg, D H

    Published in Annals of neurology (01-09-1987)
    “…To determine if galactocerebroside (GalC) is a target antigen in the human demyelinating disorders multiple sclerosis, Guillain-Barré syndrome, and chronic…”
    Get more information
    Journal Article
  18. 18